INFORMED CONSENT POLICIES
Edisciences Journals (Arguments of Geriatric Oncology - AGO, Journal of Cancer Rehabilitation - JCR, Supportive Palliative Cancer Care - SPCC, International Journal of Integrative Oncology - IJIO) undertake to apply informed consent in the field of research ethics, based on the Declaration of Helsinki: Declaration of ethical principles for medical research and the ICMJE recommendations for conduct, reporting, editing and publication of academic work in medical journals.
Patients have a right to privacy which should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs or family trees unless the information is essential for scientific purposes and the patient (or parent or guardian) provides written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potentially identifiable material could be available via the Internet and in print after publication. Patient consent must be written and filed with the journal, authors, or both as required by local law or regulation. Non-essential identification details should be omitted. In case of doubts about the possibility of remaining anonymous, it is necessary to obtain informed consent. For example, masking the eye region in patient photographs is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide guarantees and editors should note that such alterations do not distort the scientific meaning. Once informed consent is obtained, it should be indicated in the published article.
Informed consent
(Based on the Declaration of Helsinki: Statement of Ethical Principles for Medical Research)
The participation of subjects capable of giving informed consent as subjects in medical research must be voluntary.In medical research involving human subjects capable of giving informed consent, each potential subject must be adequately informed of the objectives, methods, sources of funding, any conflicts of interest, the institutional affiliations of the researcher, the expected benefits and potential risks of the study and the inconvenience it may entail, post-study arrangements and any other relevant aspects of the study. The prospective subject must be informed of the right to refuse to participate in the study or to withdraw consent to participate at any time without retaliation. Particular attention should be paid to the specific information needs of individual potential parties as well as the methods used to provide the information. After making sure that the prospective person understands the information, the physician or other suitably qualified individual should then seek the prospective person's freely given informed consent, preferably in writing. If the consent cannot be expressed in writing, the unwritten consent must be formally documented and witnessed. All medical research subjects should have the opportunity to be informed about the overall outcome and results of the study. When seeking informed consent for participation in a research study, the physician should be particularly cautious if the prospective subject is in an addictive relationship with the physician or may consent under duress. In such situations, informed consent must be sought from an appropriately qualified individual who is completely independent of this relationship. For a potential research subject who is unable to provide informed consent, the physician must seek informed consent from the legally authorized representative. These individuals should not be included in a research study that is unlikely to benefit them unless it is intended to promote the health of the group represented by the potential subject, but research cannot be done with people who can provide the informed consent, and research carries only minimal risk and minimal burden. When a potential research subject deemed unable to provide informed consent is able to give his or her assent to decisions about participation in research, the physician must seek such consent in addition to the consent of the legally authorized representative. The dissent of the potential subject should be respected. Research involving individuals who are physically or mentally unable to give consent, for example, unconscious patients, can only be done if the physical or mental condition that prevents them from giving informed consent is a necessary feature of the research team. In such circumstances, the physician must seek informed consent from the legally authorized representative. If such a representative is not available and if the research cannot be delayed, the study can proceed without informed consent provided that the specific reasons for the involvement of subjects with a condition that makes them unable to give informed consent have been indicated in the protocol. research and in the study was approved by a research ethics committee. Consent to stay in research must be obtained as soon as possible from the subject or a legally authorized representative. The physician should fully inform the patient which aspects of their care are research related. A patient's refusal to participate in a study or the patient's decision to withdraw from the study must never adversely affect the doctor-patient relationship. For medical research that uses identifiable human material or data, such as research on material or data contained in biobanks or similar archives, physicians must seek informed consent for its collection, storage and / or reuse. There may be exceptional situations where consent would be impossible or impractical to obtain for such searches. In such situations, research can only be done after review and approval by a research ethics committee.